GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors

LONDON, Sept. 10, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines today announced the appointment of David Gryska to the Board of Directors. Mr. Gryska will also serve as a member of the Audit Committee. Mr. Gryska brings valuable global pharmaceutical and biotechnology industry experience and executive-level financial leadership to GW’s Board.

To read the full press release from GW Pharmaceuticals plc, click here.

This headline brief is meant to help you stay on the pulse of your favorite cannabis-related companies. Sometimes, just figuring out which marijuana stocks may be moving can be one of the toughest parts of trading and investing in them.

Every day, The Daily Marijuana Observer seeks to keep stakeholders informed with as much of the latest news possible to keep you informed of any catalysts that may impact the companies you care about. Be sure to subscribe to cannabis stock updates here, subscribe to cannabinoid biotech updates here and GW Pharmaceuticals Updates here so you never miss a thing.